Speakers
Advisory Board Members 2025
Dr. Manal M. Younus
Head of the Iraqi Pharmacovigilance Centre - MOH, Iraq
Dr. Manal Younus is currently the head of the Iraqi...
Dr. Ahmed Hegazy
Managing Director - PVigilant Health & Pharmacovigilance & Medical Affairs Consultant
Dr. Ahmed Hegazy is a Physician by education and holds...
DR. EMAN GOMAA
International Operations & Capabilities Lead - AbbVie
Eman has a wealth of experience in PV since 2012,...
Speakers 2025
The GCC Pharmacovigilance Training 2025 gathers experts to explore the latest advancements in drug safety, regulatory updates, risk management, and compliance in the Gulf region.
Dr. Reem El Essa
Dr. Reem Al-Essa has a PhD in Pharmaceutical Regulations, MBA General and Strategic Management, MSc in PV and Pharmacoepidemiology, MSc Health Economics and Pharmacoeconomics and BSc. Pharmacy (Honours), with a long and diversified experience in both government and private sectors in Kuwait.
She started her career in Kuwait Ministry of Health, Drug and Food Control, Pharmaceutical and Herbal Medicines Registration and Control Administration, holding the position of Drug Registration Superintendent. She was appointed in the position of Coordination and Development Superintendent at the Pharmaceutical Services Administration and then became the Director of Drug Inspection Administration (DIA) in addition to holding her role as a Pharmacovigilance Superintendent in Kuwait Office for Pharmacovigilance Surveillance (KOPS).
Dr. Reem El Essa
Director of Drug Inspection Administration | Pharmacovigilance Superintendent - Ministry of Health, Kuwait
Dr. Reem Al-Essa has a PhD in Pharmaceutical Regulations, MBA...
Dr. Noura Abdelaal
She is a qualified professional with 7 years of experience in the Drug Department, having worked across multiple functions, including the regulation of Narcotics, Psychotropics, and Precursor Chemicals. Her expertise extends to conducting GMP audits both locally and internationally, monitoring drug quality and safety, and investigating malpractice within the industry, all with a focus on ensuring the safe use of medicines across the country.
She has played a pivotal role in strengthening MOHAP’s partnerships with other federal entities, including the Ministry of Interior, the Federal Customs Authority, and the Weapons and Hazardous Substances Office, as well as collaborating with international organizations such as the World Health Organization (WHO) and the International Narcotics Control Board (INCB).
Dr. Noura Abdelaal
Head of Regulating Controlled Substances & Products, & Precursor Chemicals Section, & Head of Pharmacovigilance Section - Emirates Drug Establishment (EDE), UAE
She is a qualified professional with 7 years of experience...
Dr. Katya Nabeel Ailabouni
Dr. Katya Nabeel Ailabouni is a Clinical Pharmacist with extensive experience in the UAE Ministry of Health. She holds an M. Pharm. in Clinical Pharmacy (2024, Al Ain University, UAE) and a B.Sc. in Pharmacy (1999, Philadelphia University, Amman, Jordan).
Since 2004, Dr. Katya has worked with the Ministry of Health’s Registration and Drug Control Department. From 2005-2008, she served as a Registration Officer, handling New Drug Applications, renewals, and manufacturing facility registrations. Since 2008, she has been a Pharmacovigilance Officer and a reporter for the UAE National Pharmacovigilance Committee.
Earlier in her career, Dr. Katya was the Pharmacist-in-Charge at Al Nahdha Pharmacy, Abu Dhabi (2002-2003), and a Pharmacist at Mermaid Pharmacy, Abu Dhabi (1999-2001).
Dr. Katya Nabeel Ailabouni
Clinical Pharmacist & Pharmacovigilance Officer - Emirates Drug Establishment (EDE), UAE
Dr. Katya Nabeel Ailabouni is a Clinical Pharmacist with extensive...
Dr. Mais Al-Khreishah
Dr. Mais al-khreishah, Senior specialist pharmacist in Jordan food and drug administration Currently hold head of lab affair and follow up department position, she has studied pharmacy at Jordan university worked in import and export department, pharmaceutical and herbal product unit, registration department and royal medical service.
She participated in a number of committees in JFDA, Currently Chairman of the LAB Affair Committee and member in post marketing surveillance committee and specification of secondary packaging material committee.
Dr. Mais Al-Khreishah
Head of Lab Affair & Follow Up Department – Jordan Food & Drug Administration
Dr. Mais al-khreishah, Senior specialist pharmacist in Jordan food and...
Ph. Taqwa Maqatef
Pharmacist Taqwa is a head of pharmacovigilance devision in rational drug use and pharmacovigilance department with 15 years experince in clinical studies and pharmacovigilance. Ph. Taqwa holds a Mater degree in clinical pharmacy from the university of jordan. My responsibilities include the oversee adverse event reporting, risk management strategies and ensuring compliance with regulatory requirements to maintaining the highest standards of patient safety and fostering cross-functional collaboration to achieve organizational goals.
Ph. Taqwa Maqatef
Head of Pharmacovigilance Division in Rational Drug Use and Pharmacovigilance Department - Jordan Food & Drug Administration
Pharmacist Taqwa is a head of pharmacovigilance devision in rational...
Dr. Doaa Soliman
Dr. Doaa Soliman holds a B.Sc. in Pharmaceutical Science, an Egyptian Board of Healthcare Management certification, and a master’s in healthcare quality management.
With 10 years of experience in the healthcare sector, Doaa has worked as an inpatient and community pharmacist, as well as in supply chain management, specializing in pharmacovigilance (PV). As an Administrative Manager, she oversees three units: PV Training, PV Inspection, and Pharmacovigilance System Master File (PSMF) Assessment.
She has contributed to the Egyptian Drug Authority’s (EDA) global benchmarking program with the World Health Organization (WHO) and led PV inspections across Egypt, ensuring compliance with safety standards along with providing PV training programs to stakeholders.
Dr. Doaa Soliman
Accreditation and development Administration Manager, Pharmacovigilance General Administration - Egyptian Drug Authority (EDA)
Dr. Doaa Soliman holds a B.Sc. in Pharmaceutical Science, an Egyptian Board of...
Dr. Heba Khalil Mohamed
General Manager of General Administration of Clinical Trials - Egyptian Drug Authority (EDA)
Dr. Mona Al Moussli
Dr. Mona Al Moussli is a trailblazer in the field of pharmaceutical and medical device regulatory affairs in the Middle East. With over twenty years of experience, she has firmly established herself as a seasoned professional renowned for her unparalleled expertise in navigating the intricacies of healthcare regulations
Throughout her career, Dr. Al Moussli has demonstrated an unwavering dedication to upholding the highest standards of ethics and compliance within the industry. In 2013, she co-founded PRA Consultancy, a firm that has since become synonymous with regulatory excellence in the region.
Her impact transcends traditional boardroom boundaries as she actively works to shape the future of healthcare regulation through education and advocacy. Notably, Dr. Al Moussli played a pivotal role in the inception of the GCC Regulatory Affairs (RA) Course, a pioneering certification program designed to nurture the next generation of industry experts.
Fueled by her passion for advancing health and safety standards, Dr. Al Moussli has spearheaded numerous initiatives, including the renowned GCC Regulatory Affairs Pharma Summit and other significant gatherings focused on pharmaceutical-related regulations in the region.
Dr. Al Moussli’s commitment to advancing regulatory standards transcends borders, as evidenced by her initiation of the AFRI Summit. This crucial platform facilitates discussions on pharmaceutical and medical device regulations in Africa, fostering knowledge sharing and collaboration among stakeholders to improve healthcare outcomes across the continent.
Beyond her professional achievements, Dr. Al Moussli remains actively involved in community engagement, serving as an advisory board member at Dubai Pharmacy College and lending her expertise to the Women’s Business Council at the Dubai Chamber of Commerce. In recognition of her outstanding contributions, Dr. Mona Al Moussli was elected as a board member of the Emirates Medical Association – Pharmacy chapter for consecutive terms in 2021 and 2022.
Dr. Mona Al Moussli
Chairman of GCC Regulatory Affairs Pharma Summit
Dr. Mona Al Moussli is a trailblazer in the field...
Mr. Syed Zaferuddin
An accomplished Pharmacovigilance professional with over a decade of experience in Drug and Device vigilance and regulatory compliance. Currently serving as a Global Vigilance Manager and QPPV at Gulf Pharmaceuticals – Julphar, Syed has expertise in signal management, safety database administration, and global pharmacovigilance system oversight.
Syed Worked for Organizations like Jamoom Pharma, TCS (Roche), Cognizant (Novartis), Parexel, Clinovo Research lab previously.
Notable achievements include developing and validating Implementing AI based PV tools like RI, MedDRA, Literature PV tools, implementing comprehensive training programs for thousands of professionals, and authoring critical safety reports such as PSURs and RMPs. Recognized for exceptional contributions as a speaker at global platforms like the World Drug Safety Congress, Syed is a trusted partner to regulatory authorities across the GCC region.
Certified in advanced pharmacovigilance systems, ISO standards, and biosimilars, Syed thrives on building robust safety systems that ensure patient welfare worldwide.
Specialties:
Signal Management | ICSR Processing | Regulatory Inspections | Risk Minimization | Aggregate Reporting | Training and Development | PSMF Management | GCC PV Compliance
Mr. Syed Zaferuddin
Global Vigilance Manager and QPPV at Gulf Pharmaceuticals – Julphar
An accomplished Pharmacovigilance professional with over a decade of experience...
Dr. Nahed Yaish
- 21 years of experience in the Pharma Industry
- 16 years of experience as Quality Assurance Responsible Person, Qualified Person Responsible for Pharmacovigilance/Local Safety Responsible
- 6 years of experience as a Consultant for Quality Management Systems (QMS), Business Development focusing on Quality and Regulatory Affairs (RA), and Quality Pharmacovigilance
- Specializes in creating QMS documentation compliant not only with Good Manufacturing Practice (GMP) and Good Storage and Distribution Practice (GSDP) requirements, but also with Good Pharmacovigilance Practices (GVP) to meet Quality PV standards
- Holds a Diploma in Pharmacovigilance Auditing/Lead Auditor from UK
- Holds a Diploma in Pharmaceutical QMS Auditing/Lead Auditor from UK
- Certified GSDP Pharmaceutical Quality System Auditor and Quality Pharmacovigilance Auditor
- Qualified International Trainer accredited by the International College in London
- Owner and Founder of the State Of Practices Consultancy Center (SOP Center)
Dr. Nahed Yaish
QMS & PV Consultant & Trainer - SOP CONSULTANCY CENTER
21 years of experience in the Pharma Industry 16 years...
Dr. Reem Yasin
- Dr. Reem AbdelJawwad Mahmoud Yasin, the head of Quality Assurance and Pharmacovigilance in Kawkab group, one of the top and leadings pharmaceutical’s companies in Iraq
- Is a pharmacist graduated from University of Jordan and worked as lecturer there in the College of Pharmacy.
- have over 12 years of experience in the field of Integrated Quality Management, legal agreements and Pharmacovigilance in Jordan, Egypt, Iraq, GCC and Europe
- has contributed to several international and regional courses aimed at raising awareness about Pharmacovigilance and quality management system.
- Currently, I am a member of ISOP and member in Arab Quality consultants’ union (AQCU)
- Certified ISO QMS consultant
- German board in good manufacturing practices in pharmaceuticals industry
- Certified in Pharmacovigilance professional
- Certified with mini-MBA
- Certified in Risk management professional
- Certified Trainer
Dr. Reem Yasin
Quality Assurance & Pharmacovigilance Manager – Kawkab Group
Dr. Reem AbdelJawwad Mahmoud Yasin, the head of Quality Assurance...
Dr. Alaa AlDabbas
Dr Alaa Al Dabbas, co-founder and director of Inspire Pharma Consultancy, is a highly regarded expert in pharmacovigilance and regulatory compliance. With a pharmacy degree and extensive experience in the pharmaceutical industry, Alaa has built a strong foundation in ensuring patient safety and adherence to regulatory standards.
Having lived and worked in both Australia and the Middle East, she brings a wealth of knowledge in navigating diverse healthcare systems. Throughout her career, Alaa has successfully managed complex projects, optimized pharmacovigilance processes, and ensured compliance with both local and global regulatory frameworks.
Alaa completed courses on pharmacovigilance from ARCS Australia, which covered both theoretical and practical approaches. She also completed the Medicines Australia Code of Conduct course from the University of Tasmania.
Passionate about advancing pharmacovigilance practices and fostering innovation, Alaa is dedicated to ensuring the highest standards of patient safety within the healthcare industry.
Dr. Alaa AlDabbas
Co-Founder - Director, Pharmacovigilance Specialist, Regulatory and Quality Expert - Inspire Pharma Consultancy
Dr Alaa Al Dabbas, co-founder and director of Inspire Pharma...
Mrs. Alina Panourgia
Alina Panourgia has a bachelor’s degree in pharmacy from a university in Moscow, along with an MBA and an MSc in Pharmacovigilance from universities in the UK.
She has built her career in GxP Auditing, Regulatory Affairs and Pharmacovigilance, working across Europe, the US, and APAC.
Since moving from Asia to the Middle East, Alina has focused on supporting the MENA, LATAM, and CIS markets with regulatory submissions and compliance while working closely with companies in the UK, US and EU on pharmacovigilance projects and Clinical Trials.
Alina takes a hands-on approach to her work and values practical, effective solutions that help her clients navigate complex regulatory requirements.
Mrs. Alina Panourgia
PV and Regulatory Affairs Advisor – Composite Pharma, UAE
Alina Panourgia has a bachelor’s degree in pharmacy from a...
Dr. Ala Esaifan
Dr. Ala Esaifan, a dedicated Pharmacovigilance Expert at Inspire Pharma Consultancy, brings a wealth of knowledge and expertise to the field of drug safety and regulatory compliance. Ala holds a Pharmacy degree, a certification in Clinical Trial Fundamentals from Monash University, and a certification in Pharmacovigilance from UNSW. With extensive experience in ICSR handling and processing, clinical trial safety management, and literature monitoring, Dr. Esaifan has worked with various safety databases and authored comprehensive clinical safety plans across diverse therapeutic areas.
Ala has been instrumental in setting up and optimizing pharmacovigilance practices, leveraging her extensive experience across Australia and the Middle East. Collaborating with global clients, she has delivered exceptional pharmacovigilance services and ensured compliance with international regulatory standards. Passionate about improving patient safety, Dr. Esaifan is committed to advancing pharmacovigilance practices through effective collaboration and continuous innovation.
Dr. Ala Esaifan
Co-founder & Director, Pharmacovigilance Specialist, Regulatory and Quality Expert - Inspire Pharma consultancy
Dr. Ala Esaifan, a dedicated Pharmacovigilance Expert at Inspire Pharma...
Dr. Michelle Gebara
Patient Safety Lead (UAE & Gulf) - Roche Pharmaceuticals
Mr. Darren Stewart
Darren Stewart is a distinguished leader in Patient Safety, Pharmacovigilance, Regulatory Compliance and Quality, with extensive experience in the pharmaceutical industry.
As Head of International Patient Safety CMA, Darren is responsible for driving regulatory pharmacovigilance compliance and patient safety initiatives across multiple geographies, including Central and Eastern Europe, Turkey, Russia, India, the Middle East and Africa. He is dedicated to advancing risk management strategies, enhancing the patient journey through meaningful safety solutions & community collaboration as well as strengthening partnerships & knowledge between industry and regulatory bodies.
In addition to his leadership in patient safety, Darren is a sought-after professional coach, committed to empowering and inspiring others by aligning purpose with passion.
Mr. Darren Stewart
Head of International Patient Safety, CMA | F. Hoffmann-La Roche
Darren Stewart is a distinguished leader in Patient Safety, Pharmacovigilance,...
Mr. Zahir Mohamed Chouikrat
Zahir Mohamed Chouikrat serves as the Medical Lead at Sanofi’s Innovation Hub in the Gulf countries. With over a decade of diverse experience in the healthcare sector, Zahir has demonstrated experience in roles spanning Clinical Research, Medical Governance, Real-World Evidence, and Transformation. His leadership has been crucial in driving medical transformation, enhancing data generation, and leveraging real-world evidence. Zahir’s expertise in spearheading key evidence generation initiatives and forging strategic partnerships is well-recognized. Notably, he collaborated with leading Gulf experts to publish the first white paper on real-world evidence in Gulf countries. Zahir holds a Bachelor of Veterinary Science and is a certified clinical research professional from France. He is also certified in digital and the McKinsey Forward Program. Zahir remains dedicated to continuous learning and fostering impactful advancements in patient care”.
Mr. Zahir Mohamed Chouikrat
Medical Lead Innovation Hub Transformation | RWE | Operations Gulf & KSA – Sanofi
Zahir Mohamed Chouikrat serves as the Medical Lead at Sanofi’s...
Dr. Joëlle Issa – Blok
Dr. Joëlle Issa-Blok currently works at Acino MEA, UAE as Regulatory Affairs and Pharmacovigilance Director for the Middle East, Turkey and Africa region. She is as well the QPPV for the UAE and Oman.
She has 18 years’ experience in the pharmaceutical industry in different positions, starting in Regulatory Affairs Europe R&D in the Netherlands, then in various regional roles as Head of Regulatory Affairs and Pharmacovigilance MEA at Astellas where she has been building and leading different Regulatory Affairs, Pharmacovigilance teams and organizations.
She lived and worked 10 years in the Netherlands where she gained her experience in EU RA & PV regulations. Joëlle is a Pharmacist graduated from the Saint Joseph University in Beirut, in addition she holds a Masters in Science degree in Drug Innovation Research & Development from the University of Utrecht in the Netherlands.
Dr. Joëlle Issa – Blok
Regulatory Affairs & PV Director Middle East, Turkey & Africa, QPPV UAE & Oman - Acino
Dr. Joëlle Issa-Blok currently works at Acino MEA, UAE as...
Dr. Andrea Striebel
In her role as Product Manager, Andrea is responsible for the Quality and Safety Management Hubs at EXTEDO and works closely together with the entire Product Management Team. Before taking over the PM role she started as a Senior Business Consultant at EXTEDO in January 2016 and worked on customer projects. She is not only following the latest developments in pharmacovigilance and quality but also IDMP.
Before joining EXTEDO, she worked in the pharmaceutical industry for more than 11 years, focusing on pharmacovigilance topics. First, she was a scientist, and later, she took over the team leader position for global drug safety, and in 2011, she became QPPV. In her role, she was responsible for establishing and maintaining the global pharmacovigilance system within the company. Being QPPV, Andrea was also involved in audits and inspections as well as XEVMPD topics. Additionally, she gave pharmacovigilance training and held presentations at national and international conferences.
Dr. Andrea Striebel
Product Manager – EXTEDO
In her role as Product Manager, Andrea is responsible for...
Dr. Heba Ibrahim Mussallam
Research and Education pharmacist, Sheikh Khalifa medical City (SKMC), adjunct lecturer at United Arab Emirates University, College of Medicine and Health Science
Heba has been employed by SKMC at 2008 as an outpatient pharmacist then she has joined the CF multidisciplinary team at 2011 following up patients’ medication, in 2012 she was assigned as CF Specialist pharmacist at the OSC pharmacy SKMC attending special clinics with the consultants.
She obtained her MBA in 2018 and in 2019 she joined the SKMC clinical pharmacy team as Research and Education pharmacist. Heba is SEHA Pharmacy Residency program Coordinator and preceptor.
She led many pharmacy-educational and awareness campaigns at the hospital for patients and caregivers and she is the chair of SEHA International Clinical Pharmacy Conference organizing committee.
Heba obtained her Bachelor`s degree in pharmaceutical science from Applied science university in Amman Jordan and her MBA from NYIT Abu Dhabi and master of clinical pharmacy program at Al Ain University.
Dr. Heba Ibrahim Mussallam
Chair, Organizing Committee SKMC Pharmacy Education & Clinical Pharmacist - Sheikh Khalifa Medical City
Research and Education pharmacist, Sheikh Khalifa medical City (SKMC), adjunct...
Dr. Nermin Hassan
Dr. Nermin Hassan, Pharmacovigilance Head/Auditor Middle East and Africa in RAY. With over 15 years of experience in healthcare industry providing innovative solutions for Multinational Marketing Authorization Holders in Pharmacovigilance, Clinical Operations and Quality Assurance.
Over the past 15 years she performed multiple PV audits and managed the PV activities of different multinational pharmaceutical companies. In addition, she initiated, led and participated in the widening the coverage of RAY PV Services to cover middle east, Europe, APAC region North Africa and Sub-Saharan countries including managing different PV systems, compliance measures, procedural documents, Quality management systems, different PV databases and their reporting rules verification and compliance, patient support programs, Phase 2-4 clinical trials exposure and ensuring personal data protection, confidentiality and integrity.
Dr. Nermin Hassan
Pharmacovigilance Head/Auditor, Middle East and Africa - RAY "Contract Research Organization"
Dr. Nermin Hassan, Pharmacovigilance Head/Auditor Middle East and Africa in...
Dr. Aya Eliskandarany
Associate Director, Patient Safety, Gulf Countries & Pakistan - AstraZeneca
Dr. Yasmine Fekry
Yasmine Fekry is a seasoned pharmacovigilance and patient safety expert with over 15 years of experience, specializing in regulatory compliance and safety frameworks across the Middle East. Since 2013, she has developed deep expertise in pharmacovigilance regulations, regulatory mapping, and harmonization, with a focus on the Gulf region, Saudi Arabia, and the Levant.
She specializes in navigating complex regulatory frameworks, ensuring compliance with both local and international standards, and fostering collaboration between marketing authorization holders (MAHs) and health authorities. Yasmine is dedicated to patient safety, Passionate about enhancing healthcare outcomes, she actively leads initiatives that drive regulatory excellence and promote a safer, more compliant pharmaceutical landscape across the region.
Dr. Yasmine Fekry
Middle East Multi Country Safety Head, Global Pharmacovigilance - Sanofi
Yasmine Fekry is a seasoned pharmacovigilance and patient safety expert...
Dr. Eslam El Berry
He is a Global Safety Senior Manager at Amgen with over 23 years of experience in the pharmaceutical and healthcare industries. He has held leadership roles in pharmacovigilance, medical affairs, clinical research, quality assurance, and compliance across Amgen, Pfizer, Takeda in the Middle East and Africa countries (MEA).
Dr Eslam is a strategic thinker and subject matter expert in drug safety, risk management, and audit and inspection readiness. He has successfully led regional and global pharmacovigilance projects, ensuring compliance with regulatory requirements and internal policies. With a Master’s degree in Pharmacovigilance and Pharmacoepidemiology from the University of Bordeaux, France, Dr. Eslam combines academic expertise with hands-on experience in shaping safety regulations, crisis management, and operational efficiency.
Additionally, Dr. Eslam was one of the Pharmacovigilance Association in Middle East (PHAME) founder in 2015.His contributions have been recognized through invitations as a speaker at pharmacovigilance conferences and advisory roles with health authorities. Dr. Eslam is passionate about patient safety, innovation, and leadership development, continuously striving to enhance drug safety processes and industry standards.
Dr. Eslam El Berry
Global Safety Senior Manager - Amgen
He is a Global Safety Senior Manager at Amgen with...
Dr. Raghda Mohamed Hassan
Dr. Raghda has rich experience in Pharmacovigilance and Patient Safety since 2011 when she starts establishment new pharmacovigilance system in Middle East and North Africa at Eli-Lilly from scratch.
she was working hand by hand with regulatory authority bodies within Middle East and North Africa region to implement and execute Arab Guidelines for Pharmacovigilance GVP first version.
She has several senior regional roles in multinational companies like Eli Lilly, Shire and now Takeda where she got diversified experience in Patient Safety in different geographical regions including not only Middle East and Africa but also some European countries like Greece, Portugal, Israel, Spain and Italy by which has been exposed to different experience that she builds on her area of expertise in Middle East and Africa region.
Dr. Raghda has passionate to Promote for Patient Safety in general and to optimize patient Safety awareness in specific within all health community sectors.
She is active member in different regional PV associations, and she is active moderators for DIA forums and different Global Pharmacovigilance events.
Dr. Raghda Mohamed Hassan
Patient Safety & Pharmacovigilance Cluster lead/Global Patient Access & Safety - Takeda
Dr. Raghda has rich experience in Pharmacovigilance and Patient Safety...
Dr. Rania Haggag
Rania Haggag is a dedicated and accomplished professional in the field of pharmacovigilance (PV), known for her commitment to ensuring the safety and efficacy of medications. Rania began her career as an intern at MSD Americas, where she worked in the Data Management Center. This early experience ignited her passion for pharmacovigilance and provided her with a solid foundation in the critical processes involved in monitoring drug safety.
Driven by her enthusiasm and determination, Rania moved up the ranks within MSD. She joined the Middle East PV office, where her skills and dedication were quickly recognized, leading to her promotion to Pharmacovigilance Lead. In this role, she demonstrated her ability to manage teams and streamline processes, ensuring compliance with regulatory standards and enhancing patient safety.
When MSD underwent a significant spin-off, Rania transitioned to Organon, where she took on the role of PV Lead for the Gulf and Levant regions. Her leadership in this position further solidified her expertise and influence in pharmacovigilance, as she played a vital role in implementing effective safety monitoring practices across multiple markets.
Rania’s career continued to flourish as she was recently promoted to Associate Director of Global Pharmacovigilance Business Excellence. In this strategic role, she focuses on driving operational excellence and advancing pharmacovigilance initiatives on a global scale, ensuring the organization meets regulatory requirements while prioritizing patient safety.
Dr. Rania Haggag
Global PV Business Excellence, Associate Director – Organon
Rania Haggag is a dedicated and accomplished professional in the...
Dr. Marian Anwar
Regional PV Operations, Middle East & Africa, PSQ - AbbVie
Dr. Mareez William
Dr. Mareez William is Egyptian and has graduated from Faculty of Pharmacy Ain Shams University in 2012.
She is currently working as Regional Pharmacovigilance Manager (META) in Acino Pharmaceuticals from 2019.
She has set up Pharmacovigilance system for Acino in Egypt, KSA & UAE and responsible for PV activities in Middle East and Turkey.
She seeks professionalism in her career life & personal life as well, so Time Management is her KEY in achieving this! Also, she is glad to join GCC Summit every year as she is passionate about Networking Growth and meeting other PV experts in the region.
Dr. Mareez William
Regional Pharmacovigilance Manager META – Acino
Dr. Mareez William is Egyptian and has graduated from Faculty...
Dr. Tarik Messaoud
Dr. Tarik Messaoud is a physician, consultant, and speaker at pharmacovigilance conferences in the USA and Canada. He holds a graduate diploma in Clinical Research and Clinical Trial Management from the University of Montreal, Canada. With 15 years of experience in pharmacovigilance, he specializes in oncology drug safety, particularly in immunotherapy and adoptive cell therapy involving checkpoint inhibitors.
Dr. Messaoud has worked with prominent pharmaceutical companies such as Merck/MSD and GlaxoSmithKline, as well as biotechnology firms focused on patient safety. He possesses extensive knowledge of pharmacovigilance regulations from Health Canada, the FDA, ICH, and the European Medicines Agency. Currently, he leads pharmacovigilance training initiatives and mentors students at McGill University and Access Clinical Research while also developing eLearning courses in pharmacovigilance.
Dr. Tarik Messaoud
Drug Safety Physician - Access Clinical Research (US)
Dr. Tarik Messaoud is a physician, consultant, and speaker at...